rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
2005-5-26
|
pubmed:abstractText |
Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and secondary analyses of some, but not all, clinical trials suggest that they reduce the risk of colorectal cancer.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1533-4406
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2005 Massachusetts Medical Society.
|
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
352
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2184-92
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15917383-Aged,
pubmed-meshheading:15917383-Case-Control Studies,
pubmed-meshheading:15917383-Colorectal Neoplasms,
pubmed-meshheading:15917383-Diet Surveys,
pubmed-meshheading:15917383-Female,
pubmed-meshheading:15917383-Humans,
pubmed-meshheading:15917383-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15917383-Israel,
pubmed-meshheading:15917383-Logistic Models,
pubmed-meshheading:15917383-Male,
pubmed-meshheading:15917383-Pedigree,
pubmed-meshheading:15917383-Risk,
pubmed-meshheading:15917383-Risk Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Statins and the risk of colorectal cancer.
|
pubmed:affiliation |
Department of Epidemiology, University of Michigan, Ann Arbor 48109-0638, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|